1131717

Paul R. Harmatz, M.D. — FEI 3004936676

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 16, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Oakland, CA (United States)

Additional Details

Clinical Investigator (CI)